| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2002-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fea8c6bced09794ee1569ccaef5b1e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4ecd4e7fa9251816223d3c866efd315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb63e32b4f7cc62ca7d8f599b80d6fc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_661249243e8d1b48087cbd49b39b2158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef0b737a295d6412fe8a16bc04c6328e |
| publicationDate |
2004-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-520120-A |
| titleOfInvention |
New octahydro-2H-pyrido[1,2-a]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| abstract |
Disclosed are compounds of formula (I), for which the substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases mediated by an antagonist of type H3 central histamine receptors. |
| priorityDate |
2001-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |